Results 231 to 240 of about 5,499,417 (372)

LncRNA MALAT1 as a prognostic biomarker in endometrial cancer: a molecular genetics approach. [PDF]

Discov Oncol
Liu X, Xiao J, Ma J.
europepmc   +1 more source

Abstracts of the joint meeting of the Clinical Genetics Society and the Clinical Molecular Genetics Society held on 19 and 20 April 1990 at University of Newcastle upon Tyne Medical School [PDF]

, 1990
Mary Porteous, John Burn, S Proctort, C. Geoffrey Woods, Sarah Bundey, A. Malcolm R. Taylor   +5 more
openalex   +1 more source

Molecular genetics of early-onset Alzheimer's disease revisited

Alzheimer's & Dementia, 2016
Rita Cacace, K. Sleegers, C. Broeckhoven
semanticscholar   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

State of the Art on Inherited Retinal Dystrophies: Management and Molecular Genetics. [PDF]

J Clin Med
Nebbioso M, Artico M, Gharbiya M, Mannocci A, Limoli PG, Iannetta D, Donato L.   +6 more
europepmc   +1 more source

Molecular genetics of Alport syndrome: the clinical consequences [PDF]

, 1993
Bertrand Knebelmann, Corinne Antignac, Marie-Claire Gübler, Jean‐Pierre Grünfeld   +3 more
openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance. [PDF]

Curr Oncol
Millan B, Loebach L, Blachman-Braun R, Patel MH, Saini J, Linehan WM, Ball MW.   +6 more
europepmc   +1 more source

2nd European workshop on cytogenetics and molecular genetics of human solid tumors

, 1989

openalex   +1 more source

Molecular Genetics: What's Left for Clinicians? [PDF]

, 1994
Jack P. Whisnant
openalex   +1 more source